Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Male Infertility Market Poised To Hit $5.76 Billion By 2030 With A 6% CAGR
The male infertility market size has experienced significant expansion in recent years. It is projected to expand from $4.33 billion in 2025 to $4.57 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.6%. This historical growth can be linked to factors such as declining sperm quality globally, an increased prevalence of lifestyle-related infertility, the expansion of fertility clinics, growing acceptance of ART procedures, and advancements in semen analysis techniques.
The male infertility market is poised for significant expansion in the coming years. By 2030, its valuation is projected to reach $5.76 billion, exhibiting a compound annual growth rate (CAGR) of 6.0%. This anticipated growth is driven by several factors, including an increase in infertility rates linked to environmental elements, a heightened demand for IVF and ICSI procedures, advancements in fertility diagnostic technologies, a greater awareness of male reproductive health, and the broadened availability of fertility treatments in developing economies. Key trends expected during this period involve a greater uptake of assisted reproductive technologies, the expanded utilization of advanced sperm diagnostic tests, an escalating emphasis on hormonal and targeted drug therapies, the broader application of microsurgical treatments for male infertility, and enhanced awareness leading to earlier diagnosis of male infertility.
Get A Free Sample Report With In-Depth Market Insights:
Male Infertility Market Expansion Drivers: What’s Shaping Future Growth?
The future expansion of the male infertility market is expected to be propelled by increasing stress levels. Stress levels denote the intensity of emotional, physical, or mental strain encountered when responding to challenging situations or pressures. The surge in stress originates from escalating work demands, where persistent pressure and high expectations cause burnout and disrupt mental well-being and work-life balance. Elevated stress can interfere with hormone balance, diminish sperm quality, and impair sexual function, leading to male infertility. Chronic stress disturbs cortisol and testosterone levels, contributing to an increase in infertility cases. As an illustration, in May 2024, the American Psychiatric Association, a US-based professional organization of psychologists, indicated that 43% of adults in the US felt more anxious in 2024, compared to 37% in 2023 and 32% in 2022, signifying a consistent rise in anxiety levels. Consequently, the increasing stress levels are driving the growth of the male infertility market.
Male Infertility Market Segment Landscape: Which Areas Lead Development?
The male infertility market covered in this report is segmented –
1) By Treatment Type: Medication, Surgery, Assisted Reproductive Technology
2) By Test Type: Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, Other Test Types
3) By Distribution Channel: Hospitals Pharmacies, Pharmacies And Drug Stores, Online Pharmacies
4) By End-User: Hospitals And Clinics, Fertility Centers, Research Institutes, Other End-Users
Subsegments:
1) By Medication: Hormone Treatments, Gonadotropins, Antibiotics, Antiestrogens, Dopamine Agonists
2) By Surgery: Varicocelectomy, Vasovasostomy, Epididymovasostomy, Transurethral Resection of the Ejaculatory Duct (TURED), Sperm Retrieval Procedures
3) By Assisted Reproductive Technology (ART): In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Sperm Donation, Cryopreservation Of Sperm
Male Infertility Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies operating in the male infertility market are concentrating on strategic partnership approaches to enhance access to advanced fertility treatments across global markets. Strategic partnerships involve collaborations between organizations that combine resources and expertise to achieve shared objectives, helping to drive innovation, broaden market presence, and enhance R&D efforts. For instance, in June 2024, Ferring Pharmaceuticals, a Switzerland-based pharmaceutical company, joined forces with Posterity Health, a US-based male fertility clinic, to introduce a male fertility program on Ferring’s Fertility Out Loud platform designed to educate men about their fertility. This initiative provides men with a confidential online assessment and educational resources developed by reproductive urologists to aid their understanding of their fertility status and reduce the stigma associated with male infertility, which contributes to up to 50% of infertility cases. The program seeks to empower men to take early action, potentially improving a couple’s path to parenthood by addressing male fertility issues sooner and more conveniently through digital tools and telehealth.
Male Infertility Market Industry Leaders And Competitive Landscape
Major companies operating in the male infertility market are Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., NYU Langone Hospitals, Sun Pharmaceutical Industries Ltd., Cipla Limited, Ferring Pharmaceuticals, Fortis Healthcare, Vitrolife, Max Healthcare, CinnaGen Co., Aytu BioScience Inc., Zydus Hospitals and Healthcare Research Private Limited, Apricus Biosciences Inc., SCSA Diagnostics Inc., Andrology Solutions, Halotech DNA, Indira IVF, Conduit Pharmaceuticals, Shree IVF Clinics
View The Full Male Infertility Market Report:
Male Infertility Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the male infertility market in 2025. The regions covered in the male infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
